Lv6
1700 积分 2021-03-29 加入
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
5小时前
已完结
Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products
3天前
已完结
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
3天前
已完结
Development issues: antibody stability, developability, immunogenicity, and comparability
5天前
已完结
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer
6天前
已完结
Mapping the patent landscape of TROP2-targeted biologics through deep learning
7天前
已完结
Cloning of the gene encoding TROP‐2, a cell‐surface glycoprotein expressed by human carcinomas
8天前
已完结
Biochemical Characterization of Trop-2, a Cell Surface Molecule Expressed by Human Carcinomas: Formal Proof that the Monoclonal Antibodies T16 and MOv-16 Recognize Trop-2
8天前
已完结
Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan
10天前
已完结
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors
10天前
已完结
皖公网安备34019202002308
